Fed. Circ. Rejects Bid For PTAB Tribal Immunity Rehearing

Law360 (October 22, 2018, 9:52 PM EDT) -- The full Federal Circuit on Monday said it won't reconsider a panel’s ruling that tribes can face Patent Trial and Appeal Board scrutiny, likely paving the way for one of the court’s closest-watched cases to head to the U.S. Supreme Court.

The Federal Circuit shot down a request by Allergan PLC and the St. Regis Mohawk Tribe to rehear the immunity issue that has eclipsed an infringement case over patents covering the dry-eye medication Restasis. As is common, the Federal Circuit didn’t explain why both the unanimous three-judge panel and full court turned down the rehearing request.

“The St. Regis Mohawk...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!